02616.HK 財務： CStone Pharmaceuticals AI 分析

Q: 技術分析指標如何適用於 02616.HK？

根據技術分析，CStone Pharmaceuticals 的綜合信號為 Buy。CStone Pharmaceuticals 有 4 個買入信號，2 個中性信號和 1 個賣出信號。

Q: 02616.HK 的費波那契回檔水準是多少？

CStone Pharmaceuticals 的費波那契回檔水準是 高於 0% 水準。

Q: CStone Pharmaceuticals 的 RSI 是多少？

CStone Pharmaceuticals 的 RSI 目前為 61.42，表明處於 中立 狀態

Q: CStone Pharmaceuticals 接下來 12 個月的價格是多少？

CStone Pharmaceuticals 02616.HK 接下來 12 個月的價格預估為 $0。

Q: CStone Pharmaceuticals 預計會漲到多高？

據華爾街分析師稱，CStone Pharmaceuticals 預計將達到 $0 的高預測值。

首頁

股票

02616.HK

預測

CSTONE PHARMA-B (02616.HK)

CStone Pharmaceuticals

HK$6.11

-4.53%

$-0.29

休市： Jan 16, 16:00:00 HKT

關鍵數據

前收市價

$6.32

開盤價

$6.4

當日範圍

$6.08 - $6.4

52週區間

$2.02 - $13.15

交易量

3.4M

平均成交量

10.9M

每股盈餘 (TTM)

-0.32

股息收益率

市值

$8.9B

什麼是 CSTONE PHARMA-B？

Cstone Pharmaceuticals Co. Ltd. is an investment holding company, which engages in the research and development of complex biopharmaceutical products and sale of pharmaceutical products. The company is headquartered in Suzhou, Jiangsu and currently employs 93 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The firm is also engaged in the development and commercialization of immuno-oncology. The firm primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.

功能特性

交易策略

資源

市場

02616.HK 股價預測摘要

02616.HK stock price ended at $6.12 on 星期五, after dropping 3.16%

On the latest trading day Jan 16, 2026, the stock price of 02616.HK fell by 3.16%, dropping from $6.40 to $6.12. During the session, the stock saw a volatility of 5.26%, with prices oscillating between a daily low of $6.08 and a high of $6.40. On the latest trading day, the trading volume for 02616.HK decreased by 1.2M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 2.8M shares were traded, with a market value of approximately $8.9B.

02616.HK 技術面訊號

技術面訊號摘要

購買訊號 4

中性訊號 2

賣出訊號 1

Strong Sell

Sell

Neutral

Buy

Strong Buy

02616.HK 目前顯示 4 個買入訊號與 1 個賣出訊號。該股票自 12:00 AM 以來一直處於下跌趨勢狀態，在此期間價格總共變動了 -3.16%。整體而言，技術指標顯示中期後市趨勢為 Buy。

02616.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為02616.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 02616.HK？



02616.HK 的費波那契回檔水準是多少？



CStone Pharmaceuticals 的 RSI 是多少？



CStone Pharmaceuticals 接下來 12 個月的價格是多少？



CStone Pharmaceuticals 預計會漲到多高？



CStone Pharmaceuticals（02616.HK）價格

02616.HK 股價走勢圖